Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs

Abstract EN

Common care for glioblastoma multiforme (GBM) is a surgical resection followed by radiotherapy and temozolomide- (TMZ-) based chemotherapy.

Unfortunately, these therapies remain inadequate involving severe mortality and recurrence.

Recently, new approaches discovering combinations of multiple inhibitors have been proposed along with the identification of key driver mutations that are specific to each patient.

To date, this approach is still limited by the lack of effective therapy.

Hopefully, novel compounds derived from natural products are suggested as potential solutions.

Inhibitory effects of natural products on angiogenesis and metastasis and cancer suppressive effect of altering miRNA expression are provident discoveries.

Angelica sinensis accelerates apoptosis by their key substances influencing factors of apoptosis pathways.

Brazilin displays antitumor features by making influence on reactive oxygen species (ROS) intensity.

Sargassum serratifolium, flavonoids, and so on have antimetastasis effect.

Ficus carica controls miRNA that inhibits translation of certain secretory pathway proteins during the UPR.

Serratia marcescens and patupilone (EPO 906) are physically assessed materials through clinical trials related to GBM progression.

Consequently, our review puts emphasis on the potential of natural products in GBM treatment by regulating multiple malignant cancer-related pathway solving pending problem such as reducing toxicity and side effect.